MIDDLE EAR EFFUSION LEVELS OF CEFPODOXIME AFTER ORAL SUSPENSION ADMINISTRATION

本研究的目的是测定头孢泊肟的渗透性 小儿急性中耳炎中耳积液的治疗 在给予5 mg/kg（200 mg）的Vantin口服混悬液后 最大值）每日两次或10 mg/kg每日一次。这项研究提供了更多 关于头孢扑啉治疗以下疾病的有效性的信息 细菌性中耳炎厄普约翰要求我们继续 招募的患者超过了我们最初签约的15名患者。 所有患者在治疗开始后10-12天进行随访。

The purpose of this study is to determine the penetration of cefpodoxime into middle ear effusion of pediatric patients with acute otitis media following administration of Vantin Oral Suspension as 5 mg/kg (200 mg maximum) twice daily or 10mg/kg once daily. This study provides more information on the effectiveness of cefalospoons in the treatment of bacterial otitis media. We have been requested by UpJohn to continue recruitment beyond the 15 patients for whom we had originally contracted. All patients are followed up 10-12 days after the beginning of treatment.